Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region

Jian ZHAO; Jiubing XIE; Liankai ZHAO

doi:10.12259/j.issn.2095-610X.S20220930

Volume 43 Issue 9

Sep. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(9): 141-146

Jian ZHAO, Jiubing XIE, Liankai ZHAO. Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region[J]. Journal of Kunming Medical University, 2022, 43(9): 141-146. doi: 10.12259/j.issn.2095-610X.S20220930

Citation:

Jian ZHAO, Jiubing XIE, Liankai ZHAO. Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region[J]. Journal of Kunming Medical University, 2022, 43(9): 141-146. doi: 10.12259/j.issn.2095-610X.S20220930

Citation:

PDF( 1488 KB)

Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region

doi: 10.12259/j.issn.2095-610X.S20220930

1.
Fundus Disease Department of Shenyang Aier Optometry Hospital，Shenyang Liaoning 110003
2.
Tangshan Eye Hospital，Tangshan Hebei 063000
3.
Dept. of Ophthalmology，The 1st Hospital of Dandong，Dandong Liaoning 118000，China

Received Date: 2022-06-27
Available Online: 2022-09-08
Publish Date: 2022-09-29

Abstract

Abstract

Objective To investigate the effect of ranibizumab and odix on the microvascular structure of the macular region in patients with retinal vein occlusion-macular edema （RVO-ME）. Methods All patients with RVO-ME admitted and diagnosed in the ophthalmology department of our hospital were included in the screening scope, and 101 of them were selected as the research subjects. The inclusion time was from January 2020 to December 2021, and they were divided into the observation group and the control group according to the differences in treatment methods, with 51 cases and 50 cases in each group. The observation group was given intravitreal injection of ranibizumab, and the control group was given intravitreal injection of AODEX. The age, gender, best corrected visual acuity （BCVA）, macular fovea thickness （CMT）, shallow retinal capillary layer （SCP）, deep capillary layer blood flow density （DCP） and other effective rates of the two groups before and after the treatment were included in spss21.0 software to compare the treatment differences. Results （1） There was no significant difference in BCVA, CMT, SCP, and DCP between the two groups before the treatment （P > 0.05）. With the delay of treatment time, BCVA, CMT, SCP and DCP of the two groups were significantly improved ,the control group was better than the observation group and the difference was statistically significant （P < 0.05） and （2） The total effective rates of the observation group were 94.12% and 98.04% at 3 and 6 months after the treatment while the total effective rates of the control group were 84.00% and 88.00%, showing that the control group was better than the observation group and the difference was statistically significant （P < 0.05）. Conclusion Autodix treatment can effectively improve the macular microvascular structure in RVO-ME patients.
- Ranibizumab,
- AODIX,
- Retinal vein occlusion,
- Macular edema,
- Microvascular structure of macular region

FullText(HTML)

References(16)

References

[1]	Bandah-Rozenfeld D,Littink K W,Ben-Yosef T,et al. Novel null mutations in the EYS gene are a frequent cause of autosomal recessive retinitis pigmentosa in the Israeli population[J]. Investigative Ophthalmology & Visual Science,2010,51(9):4387-4394.
[2]	Quinn P M,Mulder A A,Alves C H,et al. Loss of CRB2 in Müller glial cells modifies a CRB1-associated retinitis pigmentosa phenotype into a Leber congenital amaurosis phenotype[J]. Human Molecular Genetics,2019,28(1):105-123. doi: 10.1093/hmg/ddy337
[3]	Garweg JG,Zandi S. Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment[J]. Graefes Arch Clin Exp Ophthalmol,2016,254(7):1257-65. doi: 10.1007/s00417-016-3350-x
[4]	Rosenblatt A,Udaondo P,Cunha-Vaz J,et al. A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema:The European DME registry study[J]. Ophthalmology,2020,127(3):377-393. doi: 10.1016/j.ophtha.2019.10.005
[5]	Talib M,Cauwenbergh C V,Zaeytijd J D,et al. CRB1-associated retinal dystrophies in a Belgian cohort:Genetic characteristics and long-term clinical follow-up[J]. Br J Ophthalmol,2022,106(5):696-704. doi: 10.1136/bjophthalmol-2020-316781
[6]	Yeen-Fey H,Chao A,Chen K J,et al. Clinical outcomes and predictors of response to photodynamic therapy in symptomatic circumscribed choroidal hemangioma:A retrospective case series[J]. PLoS ONE,2018,13(5):e0197088. doi: 10.1371/journal.pone.0197088
[7]	郭丽莉,程湧,邓洵,等. 激光视网膜光凝与抗VEGF疗法治疗I型ROP后远期黄斑区形态比较及其对视力预后的影响[J]. 中华实验眼科杂志,2022,40(1):47-53.
[8]	Salerno F R,Alireza A,Sandrine L,et al. Outcomes and predictors of skin sodium concentration in dialysis patients[J]. Clin Kidney J,2022,15(6):1129-1136. doi: 10.1093/ckj/sfac021
[9]	Satoshi E,Koji O,Kosuke K,et al. Predictors of Rituximab Effect on Modified Rodnan Skin Score in Systemic Sclerosis:a machine learning analysis of the DESIRES trial[J]. Rheumatology(Oxford),2020,15(7):171-173.
[10]	鞠晓妮. 眼底激光联合雷珠单抗对糖尿病性视网膜病变患者视力及并发症的影响[J]. 当代医学,2021,27(10):182-183. doi: 10.3969/j.issn.1009-4393.2021.10.077
[11]	Van der Wijk AE,Canning P,Van Heijningen RP,et al. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier[J]. Acta Ophthalmol,2019,97(2):214-224. doi: 10.1111/aos.13909
[12]	郭建新,韩佳欣,李明新,等. 糖尿病视网膜病变患者泪膜脂质层厚度与黄斑微血管改变的相关性[J]. 国际眼科杂志,2020,20(3):449-454.
[13]	彭立,张小花,劳娜,等. 康柏西普与雷珠单抗治疗视网膜静脉阻塞继发黄斑水肿的Meta分析[J]. 国际眼科杂志,2020,20(3):455-463.
[14]	陈敏华,张小花,谢青,等. 地塞米松玻璃体内植入剂对比雷珠单抗治疗糖尿病黄斑水肿的疗效及安全性的荟萃分析[J]. 临床与病理杂志,2021,41(3):615-622.
[15]	刘俐娜,钟兴武,刘红山,等. 雷珠单抗或加减驻景方对形觉剥夺性近视豚鼠眼轴和脉络膜厚度的短期影响[J]. 国际眼科杂志,2020,3(4):599-602. doi: 10.3980/j.issn.1672-5123.2020.4.04
[16]	季红英,杨林青,郭黎霞,等. 视网膜激光联合球内注射雷珠单抗治疗视网膜静脉阻塞黄斑水肿对黄斑区微血管结构变化的影响[J]. 中国医师杂志,2021,23(10):1555-1558.

Relative Articles(20)

Relative Articles

[1]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
[2]	Dongyan YANG, Hua LIN, Yuxiao ZHANG, Kunying ZHAO, Lirong XIANG, Shuda YANG, Weiyan HU. Efficacy and Safety of Bevacizumab Combined with Temozolomide for Recurrent High-Grade Glioma. Journal of Kunming Medical University, 2024, 45(4): 67-73. doi: 10.12259/j.issn.2095-610X.S20240410
[3]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44. doi: 10.12259/j.issn.2095-610X.S20241006
[4]	Ya LUO, Yanting YU, Xue ZHANG, Zhongjuan WANG. A Meta-analysis of the Risk of Secondary Infection of Tocilizumab in the Treatment of COVID-19. Journal of Kunming Medical University, 2024, 45(2): 57-64. doi: 10.12259/j.issn.2095-610X.S20240208
[5]	Wenjuan SONG, Xuejuan MA, Yue SUN, Ying GU, Yujia YE, Shumo LI, Fei GE, Liping LIU, Yue ZHAO, Yu WANG. Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography. Journal of Kunming Medical University, 2023, 44(2): 108-112. doi: 10.12259/j.issn.2095-610X.S20230217
[6]	Siqi WU, Gang CHEN, Yishuang XIAO. Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity. Journal of Kunming Medical University, 2022, 43(5): 127-132. doi: 10.12259/j.issn.2095-610X.S20220513
[7]	Jian-ping LI, Xue-ren GAO, Xiao-yan ZHANG, Ping CHEN, Su-rong CHEN, Wei-gang BIAN, Zhi-jun HUANG. Efficacy and Safety of Capecitabine Combined with Bevacizumab or Single Agent of Capecitabine as Maintenance Therapy for Advanced Colorectal Cancer. Journal of Kunming Medical University, 2021, 42(9): 119-126. doi: 10.12259/j.issn.2095-610X.S20210908
[8]	Liu Li , Xiao Li Bo , Xu Wen Rong , Liu Xiao Chen , Zhao Lian Jiu . . Journal of Kunming Medical University, 2020, 41(04): 82-86.
[9]	Li Li Ping , Zhao Hong Chao , Zhang Yun Zhu , Li Jun . . Journal of Kunming Medical University, 2020, 41(08): 52-57.
[10]	Bian Hai Xia . . Journal of Kunming Medical University,
[11]	Yang Lin Hong . . Journal of Kunming Medical University,
[12]	Chen Xian Yu . . Journal of Kunming Medical University,
[13]	Ma Shan . Effects of Liangxuehuoxue Drugs on Hyperoxia Induced Retinal Neovascular HIF-1 and NF-кB Expression in Mice. Journal of Kunming Medical University, 2012, 33(10): 1-1.
[14]	. . Journal of Kunming Medical University,
[15]	. The Relationship between Glycated Hemoglobin and Diabetic Retinopathy. Journal of Kunming Medical University,
[16]	. Effect of Compound Light Capsule on Rats' Retinal Light Injury Induced by Operation Microscope,an Electron Microscope Observation. Journal of Kunming Medical University,
[17]	. The Effect of Compound Guangming Capsule on Retinal Light Damage in SD Rats. Journal of Kunming Medical University,
[18]	Tang Mao Dan . . Journal of Kunming Medical University, 2010, 31(01): 1-1.
[19]	Li Guo Dong . . Journal of Kunming Medical University,
[20]	Wang Peng . . Journal of Kunming Medical University,